N2OFF, Inc.
NITONASDAQHealthcare● Active
$5.13
$-0.67(-11.55%)
Market Cap$4889059
P/E Ratio—
52W High$29.4
52W Low$0.57
N2OFF, Inc.（NITO）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · NITO · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | ($0.00B) | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Margin %(computed) | — | 21.43% | 79.06% | 59.82% | 68.97% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.01B | $0.00B | $0.01B | $0.01B | $0.00B |
| Total Operating Expenses | $0.00B | $0.00B | $0.01B | $0.01B | $0.01B |
| Operating Income | ($0.01B) | ($0.00B) | ($0.01B) | ($0.01B) | ($0.00B) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | ($0.00B) |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.00B) | ($0.01B) | ($0.01B) | ($0.01B) | ($0.00B) |
| Income Tax Expense | ($0.00B) | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.00B) | ($0.01B) | ($0.01B) | ($0.01B) | ($0.00B) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-3.54 | $-31.15 | $-190.05 | $-379.75 | $-504.00 |
| Wtd Avg Shares | 1.13B | 0.17B | 0.03B | 0.02B | 0.01B |
| EBITDA | ($0.00B) | ($0.01B) | ($0.01B) | ($0.01B) | ($0.00B) |
| EBITDA Margin %(computed) | — | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · B
深入了解N2OFF, Inc.
关于N2OFF, Inc.（NITO）损益表
N2OFF, Inc.（NITO）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，NITO实现营收$0.00B，毛利润($0.00B)（毛利率—），净利润($0.00B)（净利率—）。
常见问题
NITO · 4 问N2OFF, Inc.（NITO）2025财年营收为$0.00B，同比down100.0%。
NITO revenueNITO salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09